Clinical Trial Update: SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update states SPH5030 tablets are being investigated in subjects with HER2-positive advanced solid tumors in an early-phase (Phase 1) study, wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SPH5030

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: HER2-positive Advanced Solid Tumors | EARLY_Phase 1 | Status: RECRUITING